Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nawal Adnan

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|June 10, 2026
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous ThromboembolismNawal Adnan, Khawaja Uzair, Muhammad J Patel
European Heart Journal|January 30, 2026
Revisiting the EMPATICC trial in low- and middle-income countriesNawal Adnan, Laiba Amini, Muhammad Junaid Patel
Internal and Emergency Medicine|April 18, 2026
The illusion of choice: financial toxicity and the paradox of systemic therapy in advanced HCC within resource-limited settingsHassan Aziz, Nawal Adnan, Muhammad Junaid Patel
Medicine|September 15, 2022
Human monkeypox virus: An updated reviewNawal Adnan, Zargham Ul Haq, Asmara Malik, et al.
Biomimetics (Basel, Switzerland)|December 22, 2022
Anticancer Activity of Thiophene Carboxamide Derivatives as CA-4 Biomimetics: Synthesis, Biological Potency, 3D Spheroid Model, and Molecular Dynamics SimulationMohammed Hawash, Mohammed T Qaoud, Nidal Jaradat, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|January 6, 2023
Echocardiography- versus intracardiac electrocardiogram-based optimization of cardiac resynchronization therapy: A systematic reviewAbdul Sami, Bilal Mustafa, Hamza Ahmed Butt, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|June 10, 2026
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous ThromboembolismNawal Adnan, Khawaja Uzair, Muhammad J Patel
European Heart Journal|January 30, 2026
Revisiting the EMPATICC trial in low- and middle-income countriesNawal Adnan, Laiba Amini, Muhammad Junaid Patel
Internal and Emergency Medicine|April 18, 2026
The illusion of choice: financial toxicity and the paradox of systemic therapy in advanced HCC within resource-limited settingsHassan Aziz, Nawal Adnan, Muhammad Junaid Patel
Medicine|September 15, 2022
Human monkeypox virus: An updated reviewNawal Adnan, Zargham Ul Haq, Asmara Malik, et al.
Biomimetics (Basel, Switzerland)|December 22, 2022
Anticancer Activity of Thiophene Carboxamide Derivatives as CA-4 Biomimetics: Synthesis, Biological Potency, 3D Spheroid Model, and Molecular Dynamics SimulationMohammed Hawash, Mohammed T Qaoud, Nidal Jaradat, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|January 6, 2023
Echocardiography- versus intracardiac electrocardiogram-based optimization of cardiac resynchronization therapy: A systematic reviewAbdul Sami, Bilal Mustafa, Hamza Ahmed Butt, et al.
Pageof 1